update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
Published 1 year ago • 74 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:35
update on phase i study of plamotamab in r/r nhl
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:33
an update on the phase i/ii ruby trial of reni-cel gene therapy in patients with severe scd
-
2:41
israeli company on the edge of finding diabetes cure
-
7:26
clinical decision making processes typical to health professionals
-
10:53
can reni-cel help editas take the scd / tdt gene therapy lead? what could be its pricing strategy?
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:44
insights into the phase ii tidal study
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
0:50
insights into the phase ii window-2 trial
-
4:22
accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
1:30
insights into the manifest-2 study
-
25:35
investor webinar: azer-cel trial update, september 2024